Tianke Wang

Tell us more about Dao Tun, why did you decide to found it and what does the name mean?
Dao Tun is a Swiss advisory consulting company, based in the Basel region, founded in 2019 and specialised in cross-border cooperation between Europe and China, primarily in the Healthcare and Life Science industry. 

Carol Fang

Tell us more about your current role at Novartis.

I’m the Global Head of IP – Platforms which means I am an IP strategist who is a trusted advisor and thought partner to the business, focusing on innovations like engineered cell therapy and gene therapy, that can be applied across multiple disease areas.

Chui Fung Chong

Dr Chui Fung CHONG is Senior Medical Leader in Clinical Development /Medical Affairs in pharmaceutical and medtech industries across different continents, striving to advance novel therapies to positively impact patients’ lives, with track records of leading clinical development programs on large and small molecules, as well as cell therapy in the fields of gastroenterology,

Leslie Anne Fendt

Dr. Leslie Anne Fendt currently works at Roche leading the development and commercialisation of one of Roche’s first Software-As-Medical-Device (SaMD) products, while simultaneously contributing to building out Roche’s overall digital health infrastructure, operating model, and strategy. Previously at Roche she was leading the global commercialisation of a novel immunology treatment and operationalise the product launch across 100+ affiliates. Before that, Leslie held a series of roles in sales, marketing, strategy, insights, and launch excellence both at global and affiliate level.